Pro: Sugammadex Should Be Used Routinely for Reversal of Neuromuscular Blockade in Patients Undergoing Thoracic Surgery

J Cardiothorac Vasc Anesth. 2022 Jun;36(6):1788-1791. doi: 10.1053/j.jvca.2022.02.003. Epub 2022 Feb 9.

Authors

Abraham Sonny¹, Somnath Bose²

Affiliations

¹ Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address: [email protected].
² Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

PMID: 35260324
DOI: 10.1053/j.jvca.2022.02.003

No abstract available

Keywords: neuromuscular blockade; neuromuscular reversal; postoperative pulmonary complications; sugammadex; thoracic surgery.

MeSH terms

Anesthetics*
Cholinesterase Inhibitors
Humans
Neostigmine
Neuromuscular Blockade*
Neuromuscular Nondepolarizing Agents*
Sugammadex
Thoracic Surgery*

Substances

Anesthetics
Cholinesterase Inhibitors
Neuromuscular Nondepolarizing Agents
Sugammadex
Neostigmine

Grants and funding

T32 GM007592/GM/NIGMS NIH HHS/United States